Deepali Suri

Ms. Deepali Suri is President of ICON Biotech and has over two decades of experience in the industry. Ms. Suri is responsible for driving biotech strategy, delivering tailored solutions to emerging and mid-sized biotech clients, and accelerating the development of novel therapies.

With a specialty in haematology and oncology, and a deep digital innovation background, Ms. Suri has held leadership roles across biotechnology companies, CROs and large pharma including prominent organisations such as Summit Therapeutics, Sunesis Pharmaceuticals, Pharmacyclics and Pfizer.

Ms. Suri holds both a Master’s degree in Pharmacology and a Bachelor’s degree in Pharmacy from the University of Delhi, India.